NGNE Neurogene Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 11, 2026
$25,65
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$16,3052 haftanın en düşüğü
$43,6652 haftanın en yükseği
Piyasa Değeri (MRQ)
$406M
P/E
-6.1
Hisse Başına Kâr
$-4.24
Gelir
$0
rozetleriniz
52 Haftlık Aralık
$16–$44
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$80
P/E
-6.1
ROE
-33.6%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
NGNE Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$25.65
Piyasa Değeri (MRQ)
$406M
P/E
-6.1
Hisse Başına Kâr
$-4.24
Gelir
$0
ROE
-33.6%
52 Haftlık Aralık
$16–$44
NGNE Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 19 Aralık 2023 | 1-for-4 | Ters |
| 25 Eylül 2023 | 1-for-5 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$02018-12-31 → 2025-12-31
Hisse Başına Kâr$-4.242020-12-31 → 2025-12-31
Serbest Nakit Akışı$-78M2016-12-31 → 2025-12-31
Net kar marjı·2022-12-31 → 2024-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | NGNE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -6.15Y ort. ≈-21.6 | ≈-21.6 | · | · | |
| F/D (MRQ) | 1.95Y ort. ≈7.4 | ≈7.4 | 2.9 | Düşük değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | -4.65Y ort. ≈-20.7 | ≈-20.7 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -4.75Y ort. ≈-21.9 | ≈-21.9 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 1.55Y ort. ≈1.2 | ≈1.2 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | NGNE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -28.9%5Y ort. ≈-30.3% | ≈-30.3% | -17.8% | Zayıf | |
| ROE | -33.6%5Y ort. ≈-549.1% | ≈-549.1% | -18.7% | Zayıf | |
| ROIC | -39.0% | · | -32.5% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | NGNE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 10.65Y ort. ≈14.4 | ≈14.4 | 11.6 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 16.45Y ort. ≈14.2 | ≈14.2 | 2.9 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | NGNE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.05Y ort. ≈0.0 | ≈0.0 | 0.0 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$0.00 | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
5.9%
Sonraki Rapor
Kas 11, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 10, 2026 | $-1.53 | $-1.45 | -5.4% |
| 31 Mart 2026 | May 8, 2026 | $-1.39 | $-1.32 | -5.1% |
| 31 Aralık 2025 | $-1.17 | $-1.21 | 3.5% | |
| 30 Eylül 2025 | $-0.99 | $-1.27 | 22.4% | |
| 30 Haziran 2025 | $-1.05 | $-1.18 | 11.1% | |
| 31 Mart 2025 | $-1.08 | $-1.08 | 0.42% | |
| 31 Aralık 2024 | $-0.99 | $-1.15 | 14.1% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $925.0K | $0 | · | · | · | · | $25M | |
| R&D Expense | $75M | $61M | $44M | $48M | $39M | · | · | $42M | |
| SG&A Expense | $28M | $23M | $11M | $9M | $22M | $17M | $19M | $16M | |
| Operating Expenses | $103M | $84M | $56M | $57M | $61M | · | $71M | $58M | |
| Operating Income | $-103M | $-83M | $-56M | $-57M | $-61M | $-34M | $-71M | $-33M | |
| Interest Expense | · | · | $12.0K | $2.0K | · | · | $1.0K | $4.0K | |
| Interest Income | $12M | $8M | $3M | $1M | · | · | · | · | |
| Other Non-op | $13M | $7M | · | $-42.0K | $-13.0K | $-44.0K | $-9.0K | $1M | |
| Pretax Income | $-90M | $-75M | $-36M | $-55M | $-61M | $-33M | $-69M | $-32M | |
| Income Tax | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-90M | $-75M | $-36M | $-55M | $-61M | $-33M | $-69M | $-32M | |
| EPS (Basic) | $-4.24 | $-4.28 | · | $-1.04 | $-1.10 | $-0.64 | · | · | |
| EPS (Diluted) | $-4.24 | $-4.28 | · | $-1.04 | $-1.10 | $-0.64 | · | · | |
| Shares (Basic) | 21,326,283 | 17,567,082 | · | 55,221,161 | 55,041,662 | 51,825,022 | · | · | |
| Shares (Diluted) | 21,326,283 | 17,567,082 | · | 55,221,161 | 55,041,662 | 51,825,022 | · | · | |
| EBITDA | $-100M | $-79M | $-52M | $-58M | $-59M | $-33M | $-71M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $104M | $137M | $148M | $82M | $142M | $193M | $143M | $77M | |
| Short-term Investments | $165M | $176M | $49M | $0 | $0 | · | · | · | |
| Prepaid Expense | $3M | $4M | $3M | $3M | · | · | · | · | |
| Other Current Assets | $168.0K | $981.0K | $1M | $630.0K | $2M | $2M | $503.0K | · | |
| Current Assets | $272M | $316M | $200M | $85M | $144M | $195M | $144M | $77M | |
| PP&E (Net) | $13M | $15M | $17M | $20M | $6M | $4M | $2M | $400.0K | |
| PP&E (Gross) | $27M | $27M | $25M | $25M | · | $4M | $3M | $843.0K | |
| Accum. Depreciation | $14M | $11M | $8M | $5M | · | $585.0K | $688.0K | $443.0K | |
| Intangibles | · | · | · | $0 | $128.0K | $347.0K | $567.0K | · | |
| Other Non-current Assets | $1M | $975.0K | $764.0K | $0 | $2M | $2M | $30.0K | · | |
| Total Assets | $289M | $336M | $223M | $109M | $163M | $211M | $147M | $78M | |
| Accounts Payable | $2M | $1M | $3M | $625.0K | $7M | $7M | $4M | · | |
| Accrued Liabilities | $11M | $10M | $17M | $5M | · | · | · | · | |
| Current Liabilities | $16M | $15M | $23M | $7M | $9M | $8M | $5M | $5M | |
| Capital Leases | $7M | $9M | $12M | $4M | $12M | $11M | $447.0K | $6.0K | |
| Other Non-current Liabilities | $51.0K | $51.0K | $203.0K | $0 | · | · | · | $319.0K | |
| Total Liabilities | $24M | $25M | $37M | $11M | $20M | $19M | $5M | $5M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Paid-in Capital | $618M | $573M | $373M | $5M | $536M | $524M | $441M | $303M | |
| Retained Earnings | $-353M | $-262M | $-187M | $-151M | $-393M | $-333M | $-300M | $-230M | |
| AOCI | · | · | · | $-21.0K | $0 | · | · | · | |
| Stockholders' Equity | $265M | $310M | $186M | $-146M | $-92M | $191M | $142M | $73M | |
| Liabilities + Equity | $289M | $336M | $223M | $109M | $163M | $211M | $147M | $78M | |
| Shares Outstanding | 15,489,800 | 14,854,725 | 12,823,665 | 0 | 0 | 42,196,296 | 37,996,849 | 23,537,368 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $1M | $785.0K | $340.0K | $289.0K | |
| Stock-based Comp | $14M | $8M | $1M | $1M | $12M | $6M | $8M | $5M | |
| Amort. of Intangibles | · | · | · | $100.0K | $200.0K | $200.0K | · | · | |
| Restructuring | · | · | · | $1M | · | $0 | · | · | |
| Other Non-cash | $-4M | $-7M | $-20M | $2M | $271.0K | $2M | $46M | · | |
| Operating Cash Flow | $-77M | $-71M | $-51M | $-53M | $-48M | $-25M | $-15M | $-32M | |
| CapEx | $1M | $808.0K | $321.0K | $2M | $3M | $2M | $879.0K | $49.0K | |
| Investing Cash Flow | $14M | $-125M | $26M | $-2M | $-3M | $-2M | $-688.0K | $56M | |
| Stock Issued | $30M | $0 | $92M | $0 | $0 | $72M | $81M | · | |
| Net Stock Activity | $30M | $0 | $92M | · | $0 | $72M | $86M | · | |
| Financing Cash Flow | $30M | $184M | $92M | $67M | $732.0K | $77M | $82M | $570.0K | |
| Net Change in Cash | $-33M | $-12M | $67M | $11M | $-50M | $50M | $66M | $25M | |
| Free Cash Flow | $-78M | $-71M | $-52M | $-47M | $-51M | $-27M | $-16M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -8930.3% | · | -3735.6% | · | · | · | · | |
| Net Margin | · | -8123.7% | · | -3638.2% | · | · | · | · | |
| Pretax Margin | · | -8123.7% | · | -3639.6% | · | · | · | · | |
| EBITDA Margin | · | -8584.9% | · | -3636.9% | · | · | · | · | |
| ROA | -28.9% | -26.9% | -21.9% | -41.2% | -32.5% | -18.6% | -61.8% | · | |
| ROE | -33.6% | -33.6% | -2580.2% | -57.6% | -40.8% | -17.0% | -66.6% | · | |
| ROIC | -39.0% | · | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 16.6 | 20.8 | 8.7 | 9.0 | 16.7 | 24.7 | 30.3 | · | |
| Quick Ratio | 16.4 | 20.6 | 8.6 | 8.7 | 16.5 | 24.4 | 30.2 | · | |
| Interest Coverage | · | · | -4631.9 | · | · | · | -70959.0 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $17.10 | $20.89 | $14.51 | $2.21 | $3.36 | $4.53 | $3.73 | · | |
| Revenue / Share | $0.00 | $0.05 | · | $0.03 | · | · | · | · | |
| Cash Flow / Share | $-3.62 | $-4.02 | · | $-0.83 | $-0.86 | · | · | · | |
| Cash / Share | $6.70 | $9.19 | $11.56 | $0.89 | $3.36 | $4.56 | $3.77 | · | |
| EPS (TTM) | $-4.24 | $-4.28 | $-60.79 | $-1.04 | $-1.10 | $-0.64 | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $925.0K | $0 | · | · | · | · | $25M | |
| Net Income TTM | $-90M | $-75M | $-36M | $-55M | $-61M | $-33M | $-69M | $-32M | |
| Market Cap | $319M | $340M | $249M | $434M | $4.09B | $11.90B | $9.36B | · | |
| P/E | -4.9 | -5.3 | -0.3 | -9.8 | -87.6 | -440.6 | · | · | |
| P/S | · | 367.1 | · | · | · | · | · | · | |
| P/B | 1.2 | 1.1 | 1.3 | 4.6 | 28.6 | 62.2 | 66.1 | · | |
| P / Tangible Book | 1.2 | 1.1 | 1.3 | · | · | 62.3 | · | · | |
| P / Cash Flow | -4.1 | -4.8 | -4.8 | -9.5 | -86.1 | -484.2 | -608.2 | · | |
| P / FCF | -4.1 | -4.8 | -4.8 | -9.3 | -80.5 | -444.1 | -575.3 | · | |
| Earnings Yield | -20.6% | -18.7% | -313.7% | -10.2% | -1.1% | -0.23% | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | · | $0 | $0 | $925.0K | · | $0 | $0 | $0 | · | · | · | |
| R&D Expense | $25M | $25M | $21M | $17M | $19M | $18M | $15M | $16M | $16M | $14M | $12M | $12M | $10M | $10M | $16M | $9M | |
| SG&A Expense | $11M | $8M | $7M | $7M | $7M | $8M | $6M | $6M | $5M | $5M | $3M | $4M | $2M | $3M | $-5M | $4M | |
| Operating Expenses | $37M | $33M | $28M | $24M | $26M | $26M | $22M | $22M | $21M | $19M | $15M | $15M | $13M | $13M | $12M | $14M | |
| Operating Income | $-37M | $-33M | $-28M | $-24M | $-26M | $-26M | $-22M | $-22M | $-20M | $-19M | $-15M | $-15M | $-13M | $-13M | $-12M | $-14M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $3.0K | · | · | · | $2.0K | · | · | |
| Interest Income | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $781.0K | $650.0K | $743.0K | $777.0K | · | · | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $-14.0K | · | $-22.0K | |
| Net Income | $-34M | $-31M | $-25M | $-21M | $-22M | $-23M | $-20M | $-20M | $-18M | $-17M | $2M | $-15M | $-12M | $-12M | $-11M | $-13M | |
| EPS (Basic) | $-1.53 | $-1.39 | $-1.12 | $-0.99 | $-1.05 | $-1.08 | $-1.00 | $-1.19 | $-1.09 | $-1.00 | · | $-32.67 | $-26.68 | $-0.26 | · | $-1.18 | |
| EPS (Diluted) | $-1.53 | $-1.39 | $-1.12 | $-0.99 | $-1.05 | $-1.08 | $-1.00 | $-1.19 | $-1.09 | $-1.00 | · | $-32.67 | $-26.68 | $-0.26 | · | $-1.18 | |
| Shares (Basic) | 22,552,032 | 22,305,734 | · | 21,168,431 | 21,055,378 | 20,996,287 | · | 16,953,443 | 16,941,524 | 16,903,735 | · | 446,255 | 444,465 | 55,420,912 | · | 11,050,207 | |
| Shares (Diluted) | 22,552,032 | 22,305,734 | · | 21,168,431 | 21,055,378 | 20,996,287 | · | 16,953,443 | 16,941,524 | 16,903,735 | · | 446,255 | 444,465 | 55,420,912 | · | 11,050,207 | |
| EBITDA | $-37M | $-33M | · | $-23M | $-25M | $-25M | · | $-21M | $-19M | $-18M | · | $-6M | $-3M | $-15M | · | $-14M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $112M | $124M | $104M | $71M | $59M | $71M | $137M | $67M | $111M | $150M | $148M | $25M | $31M | $35M | $82M | $40M | |
| Short-term Investments | $113M | $119M | $165M | $194M | $216M | $222M | $176M | $72M | $43M | $19M | $49M | · | · | · | $0 | · | |
| Prepaid Expense | $4M | $4M | $3M | $5M | $4M | $4M | $4M | $5M | $5M | $5M | $3M | · | · | · | $3M | · | |
| Other Current Assets | $132.0K | $181.0K | $168.0K | $208.0K | $970.0K | $997.0K | $981.0K | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $630.0K | $2M | |
| Current Assets | $229M | $247M | $272M | $271M | $279M | $296M | $316M | $144M | $159M | $174M | $200M | $80M | $84M | $86M | $85M | $109M | |
| PP&E (Net) | $12M | $13M | $13M | $13M | $14M | $15M | $15M | $16M | $16M | $16M | $17M | $484.0K | $561.0K | $2M | $20M | $6M | |
| PP&E (Gross) | $28M | $27M | $27M | $27M | $27M | $27M | $27M | $26M | $26M | $25M | $25M | · | · | · | $25M | · | |
| Accum. Depreciation | $16M | $15M | $14M | $13M | $13M | $12M | $11M | $10M | $10M | $9M | $8M | · | · | · | $5M | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Other Non-current Assets | $1M | $1M | $1M | $1M | $1M | $896.0K | $975.0K | $789.0K | $794.0K | $743.0K | $764.0K | $524.0K | $529.0K | $905.0K | $0 | $2M | |
| Total Assets | $244M | $263M | $289M | $288M | $297M | $315M | $336M | $164M | $180M | $195M | $223M | $90M | $94M | $98M | $109M | $127M | |
| Accounts Payable | $3M | $5M | $2M | $2M | $2M | $3M | $1M | $2M | $2M | $2M | $3M | $4M | $3M | $5M | $625.0K | $9M | |
| Accrued Liabilities | $15M | $11M | $11M | $9M | $9M | $7M | $10M | $10M | $7M | $7M | $17M | · | · | · | $5M | · | |
| Current Liabilities | $22M | $19M | $16M | $15M | $15M | $14M | $15M | $16M | $13M | $12M | $23M | $5M | $5M | $7M | $7M | $10M | |
| Capital Leases | $5M | $6M | $7M | $7M | $8M | $9M | $9M | $10M | $11M | $12M | $12M | $9M | $10M | $10M | $4M | $11M | |
| Other Non-current Liabilities | $0 | $0 | $51.0K | $51.0K | $51.0K | $51.0K | $51.0K | $51.0K | $51.0K | $203.0K | $203.0K | · | · | · | $0 | · | |
| Total Liabilities | $27M | $25M | $24M | $22M | $24M | $24M | $25M | $27M | $25M | $25M | $37M | $14M | $14M | $17M | $11M | $21M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $635M | $621M | $618M | $593M | $580M | $577M | $573M | $380M | $378M | $375M | $373M | $547M | $547M | $547M | $5M | $543M | |
| Retained Earnings | $-418M | $-384M | $-353M | $-328M | $-307M | $-285M | $-262M | $-243M | $-223M | $-204M | $-187M | $-472M | $-467M | $-465M | $-151M | $-438M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | $0 | $-13.0K | $18.0K | · | $-92.0K | |
| Stockholders' Equity | $217M | $238M | $265M | $266M | $273M | $292M | $310M | $137M | $155M | $171M | $186M | $75M | $80M | $81M | $-146M | $106M | |
| Liabilities + Equity | $244M | $263M | $289M | $288M | $297M | $315M | $336M | $164M | $180M | $195M | $223M | $90M | $94M | $98M | $109M | $127M | |
| Shares Outstanding | 15,830,504 | 15,615,786 | 15,489,800 | 14,775,285 | 14,269,264 | 14,929,566 | 14,854,725 | 13,010,867 | 12,989,208 | 12,860,995 | 12,823,665 | 8,805,284 | 44,021,429 | 42,818,346 | 0 | 42,594,602 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $813.0K | $847.0K | $694.0K | $800.0K | $800.0K | $749.0K | $781.0K | $800.0K | $800.0K | $814.0K | $850.0K | $800.0K | $800.0K | $812.0K | $2M | $323.0K | |
| Stock-based Comp | $8M | $4M | $3M | $3M | $3M | $4M | $2M | $2M | $2M | $1M | $355.0K | $-459.0K | $-514.0K | $293.0K | $-6M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | $0 | $142.0K | $2M | · | · | |
| Other Non-cash | · | $339.0K | · | · | · | $-3M | · | · | · | $-7M | · | · | · | $-349.0K | · | · | |
| Operating Cash Flow | $-24M | $-26M | $-17M | $-20M | $-19M | $-21M | $-17M | $-16M | $-16M | $-22M | $-17M | $-17M | $-10M | $-14M | $-18M | $-9M | |
| CapEx | $354.0K | $281.0K | $128.0K | $127.0K | $148.0K | $780.0K | $116.0K | $167.0K | $460.0K | $65.0K | $128.0K | $-358.0K | $-308.0K | $29.0K | $1M | $322.0K | |
| Investing Cash Flow | $6M | $46M | $30M | $22M | $7M | $-45M | $-103M | $-29M | $-24M | $30M | $26M | $-10M | $-11M | $-29.0K | $65M | $-28M | |
| Stock Issued | · | · | $21M | $10M | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $6M | $195.0K | $21M | $10M | $54.0K | $4.0K | $190M | $131.0K | $399.0K | $-7M | $94M | $-1M | $87.0K | $107.0K | $66M | $-52.0K | |
| Net Change in Cash | $-12M | $20M | $33M | $12M | $-12M | $-66M | $70M | $-44M | $-39M | $2M | $103M | $-29M | $-21M | $-13M | $114M | $-37M | |
| Free Cash Flow | · | $-26M | · | · | · | $-22M | · | · | · | $-22M | · | · | · | $-13M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -2176.7% | · | · | -533.9% | -312.5% | -1601.6% | · | -2434.5% | |
| Net Margin | · | · | · | · | · | · | · | · | -1999.1% | · | · | -433.9% | -212.5% | -1503.1% | · | -2338.5% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -2090.2% | · | · | -533.9% | -312.5% | -1566.8% | · | -2434.5% | |
| ROA | -12.7% | -10.7% | · | -9.3% | -9.2% | -8.9% | · | -15.9% | -13.5% | -11.5% | · | -4.2% | -1.8% | -11.5% | · | -8.6% | |
| ROE | -14.1% | -11.7% | · | -10.4% | -10.3% | -9.8% | · | -19.0% | -15.8% | -13.4% | · | -5.0% | -2.1% | -13.4% | · | -10.0% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.6 | 13.1 | · | 18.4 | 18.1 | 21.0 | · | 9.1 | 12.2 | 14.7 | · | 15.3 | 17.2 | 12.0 | · | 10.6 | |
| Quick Ratio | 10.5 | 12.9 | · | 18.0 | 17.8 | 20.8 | · | 8.8 | 11.8 | 14.3 | · | 4.8 | 6.4 | 5.0 | · | 3.9 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -6259.7 | · | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $13.72 | $15.23 | · | $17.97 | $19.15 | $19.54 | · | $10.56 | $11.93 | $13.28 | · | $8.54 | $1.81 | $1.90 | · | $2.48 | |
| Revenue / Share | · | · | · | $0.00 | $0.00 | · | · | $0.00 | $0.05 | · | · | $0.09 | $0.02 | $0.02 | · | $0.01 | |
| Cash Flow / Share | · | $-1.17 | · | · | · | $-0.99 | · | · | · | $-1.28 | · | · | · | $-0.24 | · | · | |
| Cash / Share | $7.11 | $7.95 | · | $4.81 | $4.12 | $4.74 | · | $5.12 | $8.55 | $11.67 | · | $2.86 | $0.71 | $0.83 | · | $0.95 | |
| EPS (TTM) | $-5.03 | $-4.55 | · | $-4.12 | $-4.32 | $-4.36 | · | · | · | · | · | · | · | · | · | $-2.02 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-111M | $-99M | · | $-85M | $-84M | $-81M | · | $-53M | $-48M | $-41M | · | $-50M | $-48M | $-52M | · | $-59M | |
| Market Cap | $498M | $315M | · | $256M | $213M | $175M | · | $546M | $473M | $655M | · | $139M | $731M | $599M | · | $545M | |
| P/E | -6.3 | -4.4 | · | -4.2 | -3.5 | -2.7 | · | · | · | · | · | · | · | · | · | -6.3 | |
| P/B | 2.3 | 1.3 | · | 1.0 | 0.8 | 0.6 | · | 4.0 | 3.0 | 3.8 | · | 1.8 | 9.2 | 7.4 | · | 5.2 | |
| P / Tangible Book | 2.3 | 1.3 | · | 1.0 | 0.8 | 0.6 | · | 4.0 | 3.0 | 3.8 | · | 1.8 | 9.2 | 7.4 | · | 5.2 | |
| P / Cash Flow | · | -12.1 | · | · | · | -8.4 | · | · | · | -30.2 | · | · | · | -46.0 | · | · | |
| Earnings Yield | -16.0% | -22.6% | · | -23.8% | -28.9% | -37.2% | · | · | · | · | · | · | · | · | · | -15.8% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $0 | $925.0K | $0 | · | · |
| Faaliyet Kâr Marjı % | · | -8930.3% | · | -3735.6% | · |
| Net Gelir | $-90M | $-75M | $-36M | $-55M | $-61M |
| Seyreltilmiş Hisse Başı Kâr | $-4.24 | $-4.28 | · | $-1.04 | $-1.10 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 16.6 | 20.8 | 8.7 | 9.0 | 16.7 |
| Cari Oran | 16.4 | 20.6 | 8.6 | 8.7 | 16.5 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-78M | $-71M | $-52M | $-47M | $-51M |
Kurumsal Sahipler (13F) 120 dosya · $562.1M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
120
Tutulan Değer
$562.1M
Yeni pozisyonlar
21
Çıkan pozisyonlar
4
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 21 (-3 önceki Ç'ye göre) | 4 (-7 önceki Ç'ye göre) | 39 (-5 önceki Ç'ye göre) | 33 (+18 önceki Ç'ye göre) | +272K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | $54.003.644 | 1.717.127 | 9,61% | Hisse senetleri |
| Casdin Capital, LLC | $48.601.603 | 1.545.361 | 8,65% | Hisse senetleri |
| Redmile Group, LLC | $44.413.659 | 1.412.199 | 7,90% | Hisse senetleri |
| RTW INVESTMENTS, LP | $42.849.241 | 1.362.456 | 7,62% | Hisse senetleri |
| EcoR1 Capital, LLC | $39.983.706 | 1.271.342 | 7,11% | Hisse senetleri |
| BlackRock, Inc. | $33.273.565 | 1.057.983 | 5,92% | Hisse senetleri |
| BAKER BROS. ADVISORS LP | $31.188.682 | 991.691 | 5,55% | Hisse senetleri |
| Balyasny Asset Management L.P. | $25.748.307 | 818.706 | 4,58% | Hisse senetleri |
| Trails Edge Capital Partners, LP | $22.483.133 | 714.885 | 4,00% | Hisse senetleri |
| TORONTO DOMINION BANK | $21.428.049 | 681.337 | 3,81% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $16.873.711 | 536.525 | 3,00% | Hisse senetleri |
| JENNISON ASSOCIATES LLC | $16.309.405 | 518.582 | 2,90% | Hisse senetleri |
| VANGUARD GROUP INC | $13.525.383 | 656.572 | 2,41% | Hisse senetleri |
| CITADEL ADVISORS LLC | $12.862.484 | 408.982 | 2,29% | Hisse senetleri |
| GREAT POINT PARTNERS LLC | $11.076.061 | 352.180 | 1,97% | Hisse senetleri |
| ArrowMark Colorado Holdings LLC | $10.770.147 | 342.453 | 1,92% | Hisse senetleri |
| FMR LLC | $9.295.393 | 295.561 | 1,65% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $9.222.612 | 293.182 | 1,64% | Hisse senetleri |
| STATE STREET CORP | $7.054.927 | 224.322 | 1,26% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $6.424.606 | 204.280 | 1,14% | Hisse senetleri |
| MORGAN STANLEY | $6.029.719 | 191.724 | 1,07% | Hisse senetleri |
| UBS Group AG | $5.387.039 | 171.289 | 0,96% | Hisse senetleri |
| BLAIR WILLIAM & CO/IL | $4.620.162 | 146.905 | 0,82% | Hisse senetleri |
| Driehaus Capital Management LLC | $4.513.956 | 143.528 | 0,80% | Hisse senetleri |
| Point72 Asset Management, L.P. | $4.463.384 | 141.920 | 0,79% | Hisse senetleri |
| MOORE CAPITAL MANAGEMENT, LP | $4.454.452 | 141.636 | 0,79% | Hisse senetleri |
| Rock Springs Capital Management LP | $3.357.288 | 106.750 | 0,60% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $3.354.457 | 106.660 | 0,60% | Hisse senetleri |
| NORTHERN TRUST CORP | $3.259.509 | 103.641 | 0,58% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $3.185.131 | 101.276 | 0,57% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.006.651 | 95.601 | 0,53% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.905.980 | 92.400 | 0,52% | Alım opsiyonu |
| DAFNA Capital Management LLC | $2.800.056 | 89.032 | 0,50% | Hisse senetleri |
| Woodline Partners LP | $2.636.611 | 83.835 | 0,47% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $2.335.540 | 74.262 | 0,42% | Hisse senetleri |
| Trexquant Investment LP | $2.319.815 | 73.762 | 0,41% | Hisse senetleri |
| JPMORGAN CHASE & CO | $1.997.551 | 61.882 | 0,36% | Hisse senetleri |
| XTX Topco Ltd | $1.743.085 | 55.424 | 0,31% | Hisse senetleri |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $1.688.244 | 52.300 | 0,30% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $1.343.984 | 42.734 | 0,24% | Hisse senetleri |
| Raiffeisen Bank International AG | $1.097.520 | 34.000 | 0,20% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.029.736 | 32.742 | 0,18% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $1.026.150 | 32.628 | 0,18% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $987.310 | 31.393 | 0,18% | Hisse senetleri |
| Bank of New York Mellon Corp | $903.897 | 28.741 | 0,16% | Hisse senetleri |
| Nuveen, LLC | $875.065 | 27.824 | 0,16% | Hisse senetleri |
| CITADEL ADVISORS LLC | $839.715 | 26.700 | 0,15% | Alım opsiyonu |
| JANE STREET GROUP, LLC | $820.499 | 26.089 | 0,15% | Hisse senetleri |
| Quadrature Capital Ltd | $764.864 | 24.320 | 0,14% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $733.729 | 23.330 | 0,13% | Hisse senetleri |
Aktivistler ve %5+ sahipler 4 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Rachel McMinn, Ph.D. | 21 Aralık 2023 | · | İlk başvuru | Pasif yatırım | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×18 başvurular | 20 Aralık 2023 | · | İlk başvuru | M&A / satış | SEC |
| Redmile Group, LLC, Jeremy C. Green | 27 Temmuz 2023 | · | İlk başvuru | M&A / satış | SEC |
| Jonathan G. Drachman | 27 Aralık 2019 | · | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 37 içeriden öğrenenler · 18 yöneticiler · 18 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Rachel Mcminn | Chief Executive Officer | 22 Eylül 2026 M | 1.345.063 | 0 | 1 | $-73.979 |
| Jonathan G Drachman | President and CEO | 02 Ağustos 2022 A | 25.000 | 0 | 0 | $0 |
| David Main | President and CEO | 07 Ağustos 2018 A | 71.530 | 0 | 0 | $0 |
| Christine Mikail Cvijic | President and CFO | 07 Temmuz 2026 S | 84.040 | 0 | 12 | $-900.010 |
| Sean Michael Smith | Interim CFO, Prin Acct Off | 10 Ağustos 2023 M | 21.637 | 0 | 0 | $0 |
| Robert Ho | Chief Financial Officer | 01 Şubat 2022 A | 21.503 | 0 | 0 | $0 |
| Kamran Alam | CFO, Vice President Finance | 07 Ağustos 2018 A | 0 | 0 | 0 | $0 |
| Lloyd Mackenzie | Chief Operating Officer | 07 Ağustos 2018 A | 0 | 0 | 0 | $0 |
| Christina Shafer | Chief Commercial Officer | 05 Mayıs 2026 A | · | 0 | 0 | $0 |
| Julie Jordan | Chief Medical Officer | 26 Mart 2026 S | 12.472 | 0 | 1 | $-18.125 |
| Stuart Cobb | Chief Scientific Officer | 13 Mart 2026 S | 30.497 | 0 | 3 | $-141.446 |
| Donna Cochener | General Counsel, SVP Legal | 02 Ağustos 2022 A | · | 0 | 0 | $0 |
| Carl Walkey | Senior Vice President | 02 Ağustos 2022 A | 1.352.489 | 0 | 0 | $0 |
| Holly Vance | General Counsel | 03 Ağustos 2021 A | · | 0 | 0 | $0 |
| Shelley Mccloskey | VP, HR and Administration | 07 Ağustos 2018 A | · | 0 | 0 | $0 |
| Abigail Jenkins | Chief Commercial Officer | 09 Mart 2018 A | · | 0 | 0 | $0 |
| David Chilton Mitchell | VP Global Regulatory & Quality | 08 Mart 2017 A | 3.575 | 0 | 0 | $0 |
| Stephen B Shrewsbury | CMO; Senior VP Clinical Dev. | 10 Mart 2016 A | · | 0 | 0 | $0 |
| Cory S. Freedland | Yönetim kurulu üyesi | 20 Şubat 2026 A | · | 0 | 0 | $0 |
| Sarah B. Noonberg | Yönetim kurulu üyesi | 20 Şubat 2026 A | · | 0 | 0 | $0 |
| Rohan Palekar | Yönetim kurulu üyesi | 20 Şubat 2026 A | · | 0 | 0 | $0 |
| Robert Keith Woods | Yönetim kurulu üyesi | 12 Haziran 2025 A | · | 0 | 0 | $0 |
| Keith Woods | Yönetim kurulu üyesi | 16 Ocak 2024 A | · | 0 | 0 | $0 |
| Erin Lavelle | Yönetim kurulu üyesi | 08 Haziran 2023 A | · | 0 | 0 | $0 |
| Martin Babler | Yönetim kurulu üyesi | 08 Haziran 2023 A | · | 0 | 0 | $0 |
| Todd E Simpson | Yönetim kurulu üyesi | 08 Haziran 2023 A | · | 0 | 0 | $0 |
| Erin M. Lavelle | Yönetim kurulu üyesi | 11 Mayıs 2021 A | · | 0 | 0 | $0 |
| Lewis T Williams | Yönetim kurulu üyesi | 11 Mayıs 2021 A | · | 0 | 0 | $0 |
| Sean P. Nolan | Yönetim kurulu üyesi | 05 Mayıs 2020 A | · | 0 | 0 | $0 |
| Daniel J Levitt | Yönetim kurulu üyesi | 14 Mayıs 2018 M | 0 | 0 | 0 | $0 |
| Gary Bridger | Yönetim kurulu üyesi | 07 Mayıs 2018 A | 0 | 0 | 0 | $0 |
| Robert Pelzer | Yönetim kurulu üyesi | 07 Mayıs 2018 A | · | 0 | 0 | $0 |
| Pfizer Inc. | 10% sahip | 10 Ağustos 2015 S | 975.403 | 0 | 0 | $0 |
| Ventures West 8 Limited Partnership | 10% sahip | 12 Mart 2014 C | 1.543.989 | 0 | 0 | $0 |
| Robert Baffi | · | 20 Şubat 2026 A | · | 0 | 0 | $0 |
| Patel Priti | · | 31 Mart 2023 M | 37.313 | 0 | 0 | $0 |
| Barbara Troupin | · | 09 Mart 2018 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 20 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,76% | 10.681 NS | 31 Temmuz 2026 | N-PORT |
| IBRN · iShares Trust | 0,48% | 986 SH | 11 Eylül 2026 | Günlük |
| IWC · iShares Trust | 0,10% | 38.527 SH | 11 Eylül 2026 | Günlük |
| IBB · iShares Trust | 0,04% | 120.007 SH | 11 Eylül 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,04% | 1.426 SH | 02 Ekim 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 9.854 SH | 19 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,01% | 290.868 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,01% | 5.395 NS | 31 Temmuz 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 65.030 SH | 19 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,00% | 12.679 NS | 31 Temmuz 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 400 NS | 31 Temmuz 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 1.381 NS | 31 Temmuz 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 4.511 SH | 03 Eylül 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,00% | 3.984 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 796 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 126.680 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 397.791 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 722 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,00% | 19.995 SH | 19 Ağustos 2026 | Günlük |
| IWN · iShares Trust | · | 104.527 SH | 11 Eylül 2026 | Günlük |
NGNE Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 15 analist
AL
Medyan hedef
$65.00
+153,4%
6 40,0%
Güçlü Al
8 53,3%
Al
1 6,7%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
7 analist · 2026-10-03Ortalama hedef $80.43 +213,6%
← Tüm hedeflerin altında
Mevcut fiyat $25.65
Düşük$46.00
Ortalama$80.43
Yüksek$166.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| NGNE | $319M | -4.9 | · | · | -33.6% | · |
| ZURA | · | · | · | · | · | · |
| ALLO | $314M | -1.6 | -76.8% | · | -59.9% | · |
| PROK | · | · | 1075.0% | -7725.2% | 6.9% | · |
| MNPR | · | · | · | · | · | · |
| CAPR | $1.66B | -12.8 | -11.6% | · | -51.1% | · |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | · |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | · |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | · |
| TECX | $391M | -5.2 | · | · | -27.7% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 11, 2026